Delivery Order SPE2DR25D2104-SPE2DR26F3QYS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,332.72 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count units) under a firm fixed-price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by November 19, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $6,756.65 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by July 25, 2025. AmerisourceBergen will perform this delivery from its corporate headquarters in Conshohocken, Pennsylvania, where the company maintains significant pharmaceutical distribution...
- The Defense Logistics Agency awarded a delivery order valued at $10,671.51 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 5 mg tablets (30-count) with a completion date of November 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The award represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $10,290.90 to supply Dapagliflozin 10 mg tablets (30-count packages) with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $26,399.23 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count units) on November 5, 2025, with completion scheduled for November 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,977.18 to AmerisourceBergen Drug Corp for Dapagliflozin 10 mg tablets (30-count) with an ultimate completion date of October 15, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $45,488.56 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count units) on September 15, 2025, with completion scheduled for September 16, 2025. This competitive, non-set-aside delivery order utilizes firm fixed-price pricing and represents a continuation of the pharmaceutical supply relationship between DLA and the prime contractor. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $1,070.46 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count packages) with an ultimate completion date of August 15, 2025. This competitively awarded contract, issued on August 14, 2025, utilizes a firm fixed price structure with no set-aside designation. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, with a contract ceiling value of $1,949.87. This firm fixed-price delivery order, with an ultimate completion date of October 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,490.04 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count package). This competitively awarded, firm fixed-price delivery order was issued on November 14, 2025, with an ultimate completion date of November 17, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. No set-aside designation was applied to this...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3QYSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,680.68 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units. This contract, which was competitively awarded with no set-aside designation, has a firm fixed price structure and an ultimate completion date of December 10, 2025. The order will be fulfilled from AmerisourceBergen's corporate offices located in Conshohocken, Pennsylvania, where the company maintains its primary distribution operations. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion master vehicle valued through December 2026 that provides comprehensive pharmaceutical and medical supply support to military and veteran healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen supplies an extensive portfolio of generic and brand-name medications, vaccines, and medical devices across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare programs. The firm fixed pricing and competitive award process reflect AmerisourceBergen's demonstrated capability to meet federal procurement requirements for critical pharmaceutical commodities supporting military medical readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 12/8/25 |